SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006362
Filing Date
2022-04-29
Accepted
2022-04-29 06:05:13
Documents
4
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220617xdef14a.htm DEF 14A 585902
2 GRAPHIC tmb-20220617xdef14a013.jpg GRAPHIC 145736
3 GRAPHIC tmb-20220617xdef14a001.jpg GRAPHIC 5561
4 GRAPHIC tmb-20220617xdef14a014.jpg GRAPHIC 136710
  Complete submission text file 0001558370-22-006362.txt   984093
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40523 | Film No.: 22869830
SIC: 2836 Biological Products, (No Diagnostic Substances)